Redeye: Alligator Bioscience (Q3 Review) - Rights Issue of up to SEK120m
Refinitiv1分未満で読めます
Redeye reviews Alligator Bioscience’s Q3 report 2025. The main event is the rights issue of SEK120m announced on Wednesday evening. The main positive event was the extensive investigator-sponsored study in bile duct cancer in France.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/
ログイン、もしくは永年無料のアカウントを作成して、このニュースを読みましょう